Management of patients with malignant and benign bone tumors. 10 Years experience of Kazakh scientific research institute of oncology and radiology

Cover Page

Cite item

Full Text

Abstract

Primary bones tumors make 0,2–1% of all oncological diseases (1,2–1,9 cases on 100 000 population). In dynamics for the past10 years according to statistical data of Republic Kazakhstan incidence is stable, mortality is decreasing, and 5-year survival increased for 10%.
Since 2012 Center of tumors of bones, soft tissue and melanomas was established. From 2005 till 2014 772 patients with primary tumors of bones and soft tissues and also metastatic bone involvement were treated.

About the authors

G. A. Serikbayev

Kazakh scientific research institute of oncology and radiology

Author for correspondence.
Email: ganiserikbaev@mail.ru

Almaty

Kazakhstan

Zh. O. Maulenov

Kazakh scientific research institute of oncology and radiology

Almaty

Kazakhstan

D. A. Tuleuova

Kazakh scientific research institute of oncology and radiology

Almaty

Kazakhstan

A. K. Kurmanaliyev

Kazakh scientific research institute of oncology and radiology

Almaty

Kazakhstan

G. S. Akhmetova

Kazakh scientific research institute of oncology and radiology

Almaty

Kazakhstan

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2015 Serikbayev G.A., Maulenov Z.O., Tuleuova D.A., Kurmanaliyev A.K., Akhmetova G.S.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-66671 от  09.11.2009.